May 03, 2022
2 min watch
Save
VIDEO: Higher dose of aflibercept yields better visual acuity in wet AMD
DENVER — A higher 8 mg dose of aflibercept for the treatment of wet AMD resulted in patients having a two- or three-letter improvement in visual acuity vs. the traditional 2 mg dose, David Brown, MD, said here at ARVO.
“The high dose may give the opportunity to dose [less frequently] and have better outcomes,” Brown, of Retina Consultants of Texas, said.
Published by:
Sources/Disclosures
Collapse
Source:
Brown D. Evaluation of 8 mg intravitreal aflibercept injection for neovascular age-related macular degeneration: Results from the phase 2 CANDELA study. Presented at: Association for Research in Vision and Ophthalmology meeting; May 1-4, 2022; Denver.
Disclosures:
Brown reports consulting for Regeneron.
Read more about